DNA damage plays a critical role in the cytotoxicity and mutagenicity elicited by carcinogens and many clinically used antineoplastic agents. While mutagenesis and cell death do not necessarily overlap mechanistically, many DNA lesions can induce both biological endpoints. This point is dramatically exposed in the clinical setting where a significant incidence of secondary cancers is attributed to the treatment of patients with antineoplastic agents for their primary cancer. Since DNA remains an extremely attractive target for anticancer agents, it is imperative to identify and eliminate the formation of promutagenic lesions while maintaining those that selectively induce cytotoxicity. Our hypothesis is that the selective formation of N3- methyladenine (3-MeA) lesions presents an approach to kill cells while minimizing mutations associated with secondary cancers. To study this issue, we have synthesized [1-methyl-4-[1-methyl 4-(3-(methoxysulfonyl)- (propanamido)pyrrole-2-carboxamido]pyrrole-2-carboxamido]propane (Me-lex), a methylating dipeptide that selectively affords 3-MeA.
The Specific Aims are: (1) To design new minor groove alkylating agents (analogues of Me-lex) with improved activity and bioavailabililty. (2) To understand the cytotoxicity and mutagenicity of specific minor groove DNA lesions induced by the compounds prepared in Aim 1, and to determine the impact of the DNA repair background. (3) To determine the mechanisms responsible for 3- MeA induced stalling of replicative DNA polymerases and translesion synthesis via by-pass polymerases using templates with 3-MeA and a stable analogue of 3-MeA. The effect of DNA sequence on these processes will also be investigated. (4) The cytotoxicity of Me-lex and the analogues synthesized in Aim 1 will be assayed in human glioma cell lines to test the hypothesis that human gliomas resistant to the cytotoxic effects of bis(2-chloroethyl)nitrosourea (BCNU) or temozolomide (TMZ) will not be cross-resistant to Me-lex and its analogs. The effects of stereotactic intratumoral delivery of Me-lex and the analogs on survival of athymic rats with intracerebral human gliomas will be evaluated and compared to similar treatments with BCNU and TMZ. The results of the above aims should provide useful information on the toxicity and tumorigenicity of 3-MeA and related DNA lesions, as well as how tumorigenicity can be avoided to afford improved and safer cancer chemotherapies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA029088-25
Application #
7439202
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Poland, Alan P
Project Start
1981-07-15
Project End
2010-05-31
Budget Start
2008-06-01
Budget End
2010-05-31
Support Year
25
Fiscal Year
2008
Total Cost
$269,905
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Whetstone, Ryan D; Wittel, Uwe A; Michels, Nicole M et al. (2016) Colon carcinogenesis in wild type and immune compromised mice after treatment with azoxymethane, and azoxymethane with dextran sodium sulfate. Mol Carcinog 55:1187-95
Iyer, Prema; Srinivasan, Ajay; Singh, Sreelekha K et al. (2013) Synthesis and characterization of DNA minor groove binding alkylating agents. Chem Res Toxicol 26:156-68
Szulik, Marta W; Voehler, Markus W; Ganguly, Manjori et al. (2013) Site-specific stabilization of DNA by a tethered major groove amine, 7-aminomethyl-7-deaza-2'-deoxyguanosine. Biochemistry 52:7659-68
Srinivasan, Ajay; Wang, Lirong; Cline, Cari J et al. (2012) Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors. Biochemistry 51:6246-59
Ganguly, Manjori; Szulik, Marta W; Donahue, Patrick S et al. (2012) Thermodynamic signature of DNA damage: characterization of DNA with a 5-hydroxy-2'-deoxycytidine·2'-deoxyguanosine base pair. Biochemistry 51:2018-27
Srinivasan, Ajay; Gold, Barry (2012) Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs. Future Med Chem 4:1093-111
Singh, Sreelekha K; Szulik, Marta W; Ganguly, Manjori et al. (2011) Characterization of DNA with an 8-oxoguanine modification. Nucleic Acids Res 39:6789-801
Monti, Paola; Broxson, Christopher; Inga, Alberto et al. (2011) 3-Methyl-3-deazaadenine, a stable isostere of N3-methyl-adenine, is efficiently bypassed by replication in vivo and by transcription in vitro. DNA Repair (Amst) 10:861-8
Monti, Paola; Traverso, Ilaria; Casolari, Laura et al. (2010) Mutagenicity of N3-methyladenine: a multi-translesion polymerase affair. Mutat Res 683:50-6
Rubinson, Emily H; Gowda, A S Prakasha; Spratt, Thomas E et al. (2010) An unprecedented nucleic acid capture mechanism for excision of DNA damage. Nature 468:406-11

Showing the most recent 10 out of 47 publications